Bioequivalence to become compulsory for generic combination drugs

Published: 2010-04-30 06:58:00

Updated: 2010-04-30 06:58:00

From this October, generic combinations drugs produced cheaply in Korea must prove they are equivalent to the patented medicines on which they are modeled, the Korea Food and Drug Administration said on April 27.

The drug agency also said that bioequivalence testing would also be a prerequisit...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK